Dr Walid Ayoub discusses recent data on surveillance and novel risk factors for hepatocellular carcinoma (HCC).

Dr Walid Ayoub has been engaged in the field of hepatology for the last 15 years. For the last two decades, he has treated patients with various forms of liver disease, including patients with liver cirrhosis and liver cancer. Dr Ayoub has served as the interim Medical Director for Liver Transplantation at Cedars Sinai Medical Center. He has been a regular speaker at regional and national liver meetings in the USA educating current and future gastroenterologists and hepatologists about liver diseases and liver cancer. He is an active member of the American Association for the Study of Liver Diseases (AASLD) and the American Society of Transplantation (AST). He also serves on the Medial Education Committee for the American Liver Foundation. He has participated in multiple pharma sponsored clinical trials on the use of direct acting antiviral therapy in patients with hepatitis C, cholestatic liver disease, hepatitis B and liver cancer. He is currently co-principal investigator on two National Institute of Health sponsored trials on the use of statins as chemoprevention for the development of liver cancer. Relevant publications Ayoub W, Geller SA, Tran T, Martin P, Vierling JM, Poordad F. Imatinib (Gleevec) Hepatotoxicity: a Case Report. J Clin Gastroenterol 2005; 39, 1:75-77. Ayoub WS, Keeffe EB. Management of Hepatitis B in Patients with HBe-Ag Negative Disease. Current Hepatitis Reports 2007;6,3: 91-95. Ayoub WS, Keeffe EB. Current Management of Chronic Hepatitis B. US Gastroenterology and Hepatology Review 2008;4,2:28-31. Ayoub, WS. Tenofovir - A New Option for the Treatment of Chronic Hepatitis B. Virus Adaptation and Treatment 2009;1:5-10. De Luna W, Sze DY, Ahmed A, Ha BY, Ayoub W, Keeffe EB, Cooper A, Esquivel C, Nguyen MH. Transarterial chemoinfusion for hepatocellular carcinoma as down staging therapy and a bridge toward liver transplantation. Am J Transplant 2009;9,5:1158-68. Ayoub WS, Esquivel CO, Martin P. Biliary complications following liver transplantation. Dig Dis Sci 2010; 55 ( 60): 1540-46. Ayoub WS, Keeffe EB. Current Antiviral Therapy of Chronic HBV infection. Aliment Pharmacol Ther 2011;34,10: 1145-58. Ho EY, Ha NB, Ahmed A, Ayoub W, Daugherty T, Garcia G, Cooper A, Keeffe EB, Nguyen MH. Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. J Viral Hepat 2012; 19: 2: e105-11. Ha NB, Ha NB, Ahmed A, Ayoub W, Daugherty TJ, Chang ET, Lutchman GA, Garcia G, Cooper AD, Keeffe EB, Nguyen MH. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Control 2012;23(3):455-62. Mair RD, Valenzuela A, Ha NB, Ayoub WS, Daugherty T, Lutchman GA, Garcia G, Ahmed A, Nguyen MH. Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies. Clin Gastroenterol Hepatol 2012;10,12:1412-17. Wong RJ, Ayoub WS. Current Treatment Strategies for the Management of Chronic Hepatitis B. JCOM 2012;20,1:36-47. Lin H, Ha NB, Ahmed A, Ayoub W, Daugherty TJ, Lutchman GA, Garcia G, Nguyen MH. Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians. J Immigr Minor Health 2013;15,6:1023-29. Nguyen, LH, Chao D, Lim JK, Ayoub W, Nguyen MH. Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review. Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies. Clin Gastroenterol Hepatol 2014:12,8:1262-6. Chao DT, Lim JK, Ayoub WS, Nguyen LH, Nguyen MH. Systematic review with meta-analysis: The proportion of Chronic Hepatitis B Patients with Normal ALT ≤ 40 IU/L and Significant Hepatic Fibrosis. Aliment Pharmacol Ther 2014:39,3:349-58. Nguyen KD, Sundaram V, Ayoub WS. Atypical causes of cholestasis. World J Gastroenterol 2014 Jul 28;20(28):9418-26 Valenzuela A, Ha NB, Gallo A, Bonham C, Ahmed A, Melcher M, Kim LH, Esquivel C, Concepcion W, Ayoub WS, Lutchman GA, Daugherty T, Nguyen MN. Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy. J Clin Gastroenterol 2015; 49(2):158-64. Sundaram V, Choi G, Jeon C, Ayoub WS, Nissen NN, Klein AS, Tran T. Donation after cardiac death Liver transplantation in primary sclerosing cholangitis: Proceed with caution. Transplantation 2015:99,5:973-78. Zhang B, Nguyen NH, Yee BE, Yip B, Ayoub WS, Lutchman GA, Nguyen MH. Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. Intervirology 2015;58(4):242-9. Annamalai A, Ayoub W, Sundaram V, Bresee B, Klein A. A first look: One year since inception of Regional Share 35 Policy. Transplant Proceedings 2015; 47(6):1585-90. Ayoub WS, Cohen E. Hepatitis B Management in the Pregnant Patient: An Update. J Clin Transl Hepatol 2016;4(3):241-247. Annamali A, Chen M, Reich H, Nourredin M, Nissen N, Ayoub WS. Advanced Imaging Modalities for Hepatocellular Carcinoma: Is MRI with EOVIST Really Better? Austin J Gastroenterol 2016;3(3):1-6.

Programme summary
  • clock Duration 5 MIN
  • clock Downloadable resources Yes
  • pdf PPTX FILE
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
HCC CONNECT

HCC CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts

Other programmes of interest

other Other
Oncology 
Biomarker testing in NSCLC: patient and caregiver awareness and understanding

Findings from a global survey presented in a poster at ESMO 2024

Experts
Prof. Christian Rolfo, Prof. Fernando López-Ríos, Dr. Rodrigo Paredes, Amy Moore, Anne-Marie Baird, Shani Shilo
Endorsed by
LUNGevity
Lung Cancer Europe IASLC
The Israeli Lung Cancer Foundation ISLB
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024

Educational programme supported by an Independent Educational Grant from Bayer.
podcast Podcast
  • download Downloadable
    Resources
  • clock 23 MIN
  • calendar Sep 2024

Educational programme supported by an Independent Educational Grant from Ipsen
conference-update Conference update
Oncology 
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers

Renowned medical experts share their insights into new data presented at ESMO 2024

  • download Downloadable
    Resources
  • clock 3 MIN
  • calendar Sep 2024

animated-video Animated Video

Episode

1

of 1

episode
Oncology 
Precision oncology in prostate cancer: tips for optimal genomic testing

From sample collection through to diagnostic modalities 

Experts
Dr Alexander Wyatt
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024

Educational programme supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.
video Video
Oncology Hemato-oncology 
Early relapsed/refractory multiple myeloma (RRMM): best practices in management

A 3-part video series on managing early RRMM from leading medical experts

Experts
Dr Elena Zamagni, Dr Fredrik Schjesvold, Dr Joseph Mikhael
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Sep 2024

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.
other Other

Episode

2

of 2

episode
Oncology 
Optimising samples for biomarker testing in lung, prostate and gastric cancer

Recommendations for best practice

Experts
Dr Alexander Wyatt, Prof. Frédéric Bibeau
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Aug 2024

Educational programme supported by an Independent Educational Grant from AstraZeneca and Amoy Diagnostics.